Geron Corporation (GERN) earnings
GERN earnings moved a median of -1.88% by the close. Quarterly and annual GERN reports and results, each read against the price at its own news timestamp. Back to the GERN overview →
30 measured GERN earnings events.
Where these GERN earnings landedvs 30 measured GERN earnings reactions
| Middle 50% of GERN earnings reactions | -4.65% to +1.52% |
|---|---|
| Median reaction (to close) | -1.88% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 GERN earnings events with a measured close landed between -4.65% and +1.52%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q GERON CORP For: Jun 30 | SEC filing · Form 10-Q | -3.13% | -1.88% | |
| Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | +6.93% | +18.98% | |
| Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026 | Press release | +0.42% | -2.08% | |
| Form 10-Q GERON CORP For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.41% | |
| Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights | Press release | -3.31% | -4.82% | |
| Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 | Press release | -0.41% | +1.31% | |
| Form 10-K GERON CORP For: Dec 31 | SEC filing · Form 10-K | -0.31% | -3.13% | |
| Form 10-Q GERON CORP For: Sep 30 | SEC filing · Form 10-Q | +0.47% | +8.41% | |
| Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Press release | +0.46% | -0.91% | |
| Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025 | Press release | +1.19% | +1.59% | |
| Form 10-Q GERON CORP For: Jun 30 | SEC filing · Form 10-Q | -0.35% | -8.45% | |
| Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights | Press release | +1.15% | +6.92% | |
| Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025 | Press release | -0.84% | -9.45% | |
| Form 10-Q GERON CORP For: Mar 31 | SEC filing · Form 10-Q | +0.39% | -2.33% | |
| Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights | Press release | +5.77% | +0.77% | |
| Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025 | Press release | -1.26% | -6.92% | |
| Form 10-K GERON CORP For: Dec 31 | SEC filing · Form 10-K | +2.81% | +8.75% | |
| Form 10-Q GERON CORP For: Sep 30 | SEC filing · Form 10-Q | +2.26% | +0.95% | |
| Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | -2.67% | -4.67% | |
| Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 | Press release | -1.53% | -1.88% | |
| Form 10-Q GERON CORP For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +2.17% | |
| Geron Corporation Reports Second Quarter 2024 Financial Results and Business Highlights | Press release | +1.57% | +3.37% | |
| Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024 | Press release | -0.95% | -2.33% | |
| Form 10-Q GERON CORP For: Mar 31 | SEC filing · Form 10-Q | -0.63% | -1.75% | |
| Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights | Press release | -4.11% | -4.59% | |
| Geron to Announce First Quarter 2024 Financial Results on May 2, 2024 | Press release | -0.28% | +5.57% | |
| Form 10-K GERON CORP For: Dec 31 | SEC filing · Form 10-K | +5.69% | -0.99% | |
| Form 10-Q GERON CORP For: Sep 30 | SEC filing · Form 10-Q | +0.78% | -7.77% | |
| Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results | Press release | +0.78% | -7.77% | |
| Geron to Announce Third Quarter 2023 Financial Results on November 2, 2023 | Press release | -0.55% | -2.19% |
Keep exploring
More GERN: analyst actions → · SEC filings → · GERN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Antares Pharma, Inc. (ATRS) | 951 | 0.00% | 43% |
| Sage Therapeutics, Inc. (SAGE) | 951 | -0.14% | 41% |
| Intellia Therapeutics, Inc. (NTLA) | 948 | -0.24% | 45% |
| Biohaven Ltd. Common Shares (BHVN) | 944 | -0.27% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.